Metastatic Non-squamous Non Small Cell Lung Cancer

DBCOND0044105Lung Diseases Thoracic and Respiratory Tract Neoplasms

Metastatic Non-squamous Non Small Cell Lung Cancer is the indication for 6 drugs in DrugBank. It is covered by 16 curated, structured indications.

Also known as: metastatic nonsquamous non-small cell lung cancer · Metastatic Non-Squamous Non-Small Cell Lung Cancer
Classified under: Lung Diseases
Thoracic and Respiratory Tract Neoplasms
Indicated drugs: Atezolizumab
Bevacizumab
Carboplatin
Paclitaxel
Pemetrexed
Sevabertinib

What you can answer from here — as of October 24, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

16Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

15Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Metastatic Non-squamous Non Small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account